Institutional investors purchased a net $202.9 thousand shares of ACOR during the quarter ended December 2016 and now own 106.11% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SCOPIA CAPITAL MANAGEMENT LP Bought 1.0 Million shares of Acorda Therapeutics Inc